Cystatin C and mortality risk in the general population: systematic review and dose response meta-analysis.
Meta-analysis · Biomarkers · 2022. Source record refreshed; an explanation has not been reviewed.
About this paper
This page identifies the publication and its source. A checked explanation of its findings is not yet available.
Reading this record
Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.
Publication details
Cystatin C and mortality risk in the general population: systematic review and dose response meta-analysis.
Jung E, Ro YS, Ryu HH et al.
Biomarkers · 2022
- PubMed ID
- 34847805
- Record checked
A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.
Keep your place in the research.
Save this source or mark it as read.